These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4098770)

  • 21. Effects of thrombolytic therapy on recanalization in different starting time of treatment after acute myocardial infarction.
    Shen L; Yang J; Hu Q; Teng Y; Han X; Yan S; Lian M; Xie M; Gu F
    Chin Med J (Engl); 1997 Jan; 110(1):53-5. PubMed ID: 9594323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thrombolytic treatment of acute myocardial infarct. 1].
    Soares-Costa JT; Soares-Costa TJ; Gabriel HM
    Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On the treatment of myocardial infarct with special reference to fibrinolytic substances].
    Heinrich HG
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):38-45. PubMed ID: 4189370
    [No Abstract]   [Full Text] [Related]  

  • 24. Thrombolytic therapy in acute myocardial infarction. Methodist Hospital experience.
    Pitts DE; Valentine RP; Brooks JA
    J Indiana State Med Assoc; 1983 Jun; 76(6):388-91. PubMed ID: 6875285
    [No Abstract]   [Full Text] [Related]  

  • 25. Aspirin augmentation of the efficacy of thrombolysis.
    O'Donnell CJ; Jonas MA; Hennekens CH
    Coron Artery Dis; 1995 Dec; 6(12):936-9. PubMed ID: 8723015
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk-benefit of thrombolysis.
    Simoons ML
    Cardiol Clin; 1995 Aug; 13(3):339-45. PubMed ID: 7585771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombolysis (Consensus about post-myocardial infarction treatment)].
    Arq Bras Cardiol; 1995 Mar; 64(3):271-80. PubMed ID: 7487519
    [No Abstract]   [Full Text] [Related]  

  • 28. [Development and results of thrombolytic therapy].
    Deutsch E; Ebringer H; Lechner K; Pilgerstorfer HW
    Wien Med Wochenschr; 1971 May; 121(20):410-5. PubMed ID: 5566996
    [No Abstract]   [Full Text] [Related]  

  • 29. [The characteristics of thrombolytic therapy in myocardial infarct in middle-aged and elderly patients].
    Teslia AN; Kolesnikov SA; Mikhaĭlov AA
    Voen Med Zh; 1999 Jul; 320(7):40-4. PubMed ID: 10484919
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnosis and treatment of intravascular coagulation processes].
    Moriau M; Masure R
    Nouv Rev Fr Hematol; 1968; 8(1):5-19. PubMed ID: 4232151
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fibrinolysis and thrombolytic therapy under laboratory control].
    Osten W
    Med Lab (Stuttg); 1966 May; 19(5):108-13 contd. PubMed ID: 5982109
    [No Abstract]   [Full Text] [Related]  

  • 32. [Thrombolytic treatment with streptokinase in acute myocardial infarct].
    Binaghi G; Repetto S; Mortarino G; Ferrari GP; Ambrosetti P
    Minerva Med; 1980 Apr; 71(16):1201-2. PubMed ID: 7375041
    [No Abstract]   [Full Text] [Related]  

  • 33. Indirect measruement of streptokinase concentration in the plasma of patients undergoing fibrinolytic treatment.
    Martin M
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):633-50. PubMed ID: 4217477
    [No Abstract]   [Full Text] [Related]  

  • 34. Thrombolysis utilisation in acute myocardial infarction in Bahrain.
    Chawla AK; Nambiar CA; Murad AA
    Indian Heart J; 1996; 48(2):155-8. PubMed ID: 8682556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of intravenous thrombolytic drugs for acute myocardial infarction.
    Naylor CD; Bronskill S; Goel V
    Can J Cardiol; 1993; 9(6):553-8. PubMed ID: 8221354
    [No Abstract]   [Full Text] [Related]  

  • 36. Single-blind randomised multicentre trial comparing heparin and streptokinase treatment in recent myocardial infarction.
    Amery A; Roeber G; Vermeulen HJ; Verstraete M
    Acta Med Scand Suppl; 1969; 505():1-35. PubMed ID: 4911123
    [No Abstract]   [Full Text] [Related]  

  • 37. [Guidelines and results of consequent fibrinolytic therapy in phlegmasia cerulea dolens].
    Paquet KJ; Popov S; Egli H
    Dtsch Med Wochenschr; 1970 Apr; 95(16):903-4. PubMed ID: 5439547
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antithrombotic therapy of ischemic heart disease].
    Liusov VA; Belousov IuB
    Kardiologiia; 1974 Jul; 14(7):113-21. PubMed ID: 4431131
    [No Abstract]   [Full Text] [Related]  

  • 39. Considerations in selecting thrombolytic and antithrombotic therapy for treatment of myocardial infarction aboard navy ships at sea.
    Balcom TA; Allingham TA
    Mil Med; 1998 Feb; 163(2):105-6. PubMed ID: 9503903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thrombolytic therapy in older venous occlusions].
    Tilsner V; Johannes E; Kalmar P; Westermann KW; Marcsek M
    Med Klin; 1972 Jan; 67(1):16-9. PubMed ID: 5058277
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.